J. L. Sun Et Al. , "Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress," Biochemical and Biophysical Research Communications , vol.722, 2024
Sun, J. L. Et Al. 2024. Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress. Biochemical and Biophysical Research Communications , vol.722 .
Sun, J. L., Kim, Y. J., Cho, W., Lim, D. S., Gwon, H. J., Abd El-Aty, A. M. A., ... Nas, M. A.(2024). Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress. Biochemical and Biophysical Research Communications , vol.722.
Sun, Jaw Et Al. "Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress," Biochemical and Biophysical Research Communications , vol.722, 2024
Sun, Jaw L. Et Al. "Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress." Biochemical and Biophysical Research Communications , vol.722, 2024
Sun, J. L. Et Al. (2024) . "Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress." Biochemical and Biophysical Research Communications , vol.722.
@article{article, author={Jaw Long Sun Et Al. }, title={Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress}, journal={Biochemical and Biophysical Research Communications}, year=2024}